Is a urinalysis showing positive leukocyte esterase, negative nitrite, and pyuria a normal finding in a patient with untreated Chlamydia trachomatis or Neisseria gonorrhoeae infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urinalysis Findings in Gonorrhea and Chlamydia Infections

Yes, positive leukocyte esterase, negative nitrite, and pyuria on urinalysis are normal and expected findings in patients with untreated Chlamydia trachomatis or Neisseria gonorrhoeae infection. These urinalysis abnormalities reflect urethral inflammation (urethritis) rather than a urinary tract infection, and should not prompt treatment with typical UTI antibiotics 1, 2.

Why These Findings Occur

  • Positive leukocyte esterase and pyuria (≥10 WBCs per high-power field) are diagnostic criteria for urethritis and are expected when gonorrhea or chlamydia cause urethral inflammation 3, 1.

  • Negative nitrite is the expected finding because C. trachomatis and N. gonorrhoeae do not produce nitrate reductase enzymes that convert urinary nitrates to nitrites—this distinguishes STI-related urethritis from typical urinary tract infections caused by gram-negative enteric bacteria 3.

  • Sterile pyuria (pyuria with negative urine culture) occurs in 74% of women with confirmed STIs, demonstrating that pyuria in the setting of gonorrhea or chlamydia does not indicate a bacterial UTI 2.

Clinical Implications

  • Do not treat these patients with typical UTI antibiotics (such as nitrofurantoin or trimethoprim-sulfamethoxazole) based on the urinalysis findings alone, as this leads to substantial overtreatment—66% of patients with STIs who received UTI antibiotics had negative urine cultures 2.

  • The appropriate treatment is dual therapy for gonorrhea and chlamydia: ceftriaxone 250 mg IM single dose plus doxycycline 100 mg orally twice daily for 7 days 4, 5.

  • Leukocyte esterase testing on first-void urine has 100% sensitivity for detecting urethral infection with gonorrhea or chlamydia in asymptomatic males, making it a useful screening tool 6.

Diagnostic Approach

  • Obtain nucleic acid amplification tests (NAATs) for both N. gonorrhoeae and C. trachomatis on first-void urine or urethral swab, as these provide the highest sensitivity and specificity available 1.

  • A Gram stain showing ≥5 polymorphonuclear leukocytes per oil immersion field in urethral secretions confirms urethritis and provides immediate presumptive diagnosis if intracellular gram-negative diplococci are seen 4, 1.

  • The presence of nitrite-positive urine does not rule out STI—in fact, 59% of nitrite-positive urines in patients with confirmed STIs had negative urine cultures, indicating that nitrite positivity can be misleading in this population 2.

Common Pitfalls to Avoid

  • Do not assume pyuria equals UTI in sexually active patients—always consider STI-related urethritis, especially in younger patients with dysuria and urinary frequency 2.

  • Do not rely on the absolute number of leukocytes to distinguish UTI from STI—while culture-positive urines averaged 34 WBCs/hpf versus 24 WBCs/hpf for culture-negative urines, this 10-cell difference is not clinically useful for individual patient decision-making 2.

  • Recognize that asymptomatic infection is common—86% of adolescent males with pyuria and positive STI cultures in one study were asymptomatic, emphasizing the need for screening in high-risk populations 7.

Partner Management

  • All sexual partners within 60 days preceding symptom onset or diagnosis must be evaluated and treated empirically for both gonorrhea and chlamydia, regardless of their symptoms or test results 1, 5.

  • Patients should abstain from sexual intercourse for 7 days after initiating therapy and until all partners complete treatment to prevent reinfection 5.

References

Guideline

Diagnostic and Management Guidelines for Urethritis Caused by *Chlamydia trachomatis* and *Neisseria gonorrhoeae*

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Treatment of Male Penile Discharge

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Empiric Treatment for Male STIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

First catch urine sediment for Chlamydia trachomatis and Neisseria gonorrhoeae culture in adolescent males with pyuria.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.